PROCEPT BioRobotics (PRCT) director receives RSU and option grants as equity pay

Rhea-AI Filing Summary

PROCEPT BioRobotics director Antal Rohit Desai received new equity awards as compensation. He was granted 3,315 restricted stock units, each representing one future share of Common Stock, increasing his reported Common Stock holdings to 38,467 shares. He also received a stock option for 5,853 shares at an exercise price of $28.78 per share. Both the RSUs and the option vest in full on the earlier of the one-year anniversary of the June 9, 2026 grant date or the next annual meeting following that date, subject to his continued service.

Insights

Equity compensation analyst

Routine director equity grants with time-based vesting, neutral for valuation.

PROCEPT BioRobotics granted director Antal Rohit Desai 3,315 restricted stock units and an option for 5,853 shares at an exercise price of $28.78. These awards appear to be standard board compensation rather than market purchases.

The RSUs and options vest fully on the earlier of the one-year anniversary of the June 9, 2026 grant date or the next annual meeting, conditioned on continued service. Such time-based vesting structures are common and are designed to align directors with shareholders over the vesting period.

Following the grant, Desai reports ownership of 38,467 shares of Common Stock and holds the new option covering 5,853 shares. Given the compensation-related nature and modest scale of these awards, this filing is best viewed as routine governance and not a directional signal on the stock.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Desai Antal Rohit

Role null

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	5,853	$0.00	--
Grant/Award	Common Stock	3,315	$0.00	--

Holdings After Transaction: Stock Option (Right to Buy) — 5,853 shares (Direct, null); Common Stock — 38,467 shares (Direct, null)

Footnotes (1)

1. These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The securities shall vest in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date. The Stock option was granted on June 9, 2026, and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.

Key Figures

RSU grant: 3,315 units Option grant size: 5,853 shares Option exercise price: $28.78 per share +2 more

5 metrics

RSU grant 3,315 units Restricted stock units granted June 9, 2026

Option grant size 5,853 shares Stock option covering Common Stock

Option exercise price $28.78 per share Stock option strike price

Shares after grant 38,467 shares Common Stock held following RSU award

Option expiration 2036-06-08 Stock option expiration date

Key Terms

restricted stock units (RSUs), Stock option, exercise price, annual meeting, +1 more

5 terms

restricted stock units (RSUs) financial

"These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock."

Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.

Stock option financial

"The Stock option was granted on June 9, 2026, and vests in full on the earlier to occur of (i) the one-year anniversary..."

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

exercise price financial

"conversion_or_exercise_price: "28.7800""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

annual meeting financial

"or (ii) the date of the next annual meeting following the grant date, subject to continued service..."

A company's annual meeting is a yearly gathering where owners (shareholders) and the board review performance, ask questions, and vote on key matters like electing directors, approving auditor choices, and sometimes setting pay or dividend policies. For investors it matters because decisions made and votes cast can change who runs the company, influence strategy and payouts, and affect the value or direction of their investment—similar to a homeowners’ meeting where rules and leaders that shape your property’s value are decided.

vesting financial

"The securities shall vest in full on the earlier to occur of (i) the one-year anniversary of the grant date..."

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Desai Antal Rohit

(Last) (First) (Middle)

C/O PROCEPT BIOROBOTICS CORPORATION

150 BAYTECH DRIVE

(Street)

SAN JOSE CALIFORNIA 95134

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PROCEPT BioRobotics Corp [ PRCT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/09/2026		A(1)		3,315	A	$0	38,467	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$28.78	06/09/2026		A		5,853		(2)	06/08/2036	Common Stock	5,853	$0	5,853	D

Explanation of Responses:

1. These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The securities shall vest in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.

2. The Stock option was granted on June 9, 2026, and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.

Remarks:

	/s/ Jonathan Stone, Attorney-in Fact for Mr. Antal Rohit Desai	06/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What equity awards did PROCEPT BioRobotics (PRCT) director Antal Rohit Desai receive?

Director Antal Rohit Desai received 3,315 restricted stock units and a stock option for 5,853 shares at an exercise price of $28.78. These awards are compensation-related grants, not open-market purchases, and are tied to his continued board service over the vesting period.

How do the new grants affect Antal Rohit Desai’s PROCEPT BioRobotics share holdings?

After the grant, Antal Rohit Desai reports 38,467 shares of PROCEPT BioRobotics Common Stock. In addition, he holds a new stock option covering 5,853 shares. The RSUs represent contingent rights to shares that will be delivered only if vesting conditions are met.

When do Antal Rohit Desai’s new PROCEPT BioRobotics RSUs and options vest?

Both the 3,315 restricted stock units and the 5,853-share stock option vest in full on the earlier of the one-year anniversary of the June 9, 2026 grant date or the next annual meeting. Vesting requires Desai’s continued service through the applicable vesting date.

Are Antal Rohit Desai’s PROCEPT BioRobotics transactions open-market buys or compensation grants?

The filing shows compensation grants, not open-market purchases. The Form 4 classifies both transactions under code A, meaning grant, award, or other acquisition. The RSUs and options were awarded at a $0.00 grant price, with the option exercisable at $28.78 per share.

What is the structure of PROCEPT BioRobotics (PRCT) director stock options granted to Desai?

Desai’s stock option covers 5,853 shares of Common Stock at an exercise price of $28.78 per share, expiring in 2036. It vests fully on the earlier of the one-year anniversary of the June 9, 2026 grant or the next annual meeting, subject to continued service.

What do the PROCEPT BioRobotics RSUs granted to Antal Rohit Desai represent?

The 3,315 RSUs each represent a contingent right to receive one share of PROCEPT BioRobotics Common Stock. They do not deliver shares immediately; instead, they convert into shares only if the vesting condition—continued service until the specified vesting date—is satisfied.